Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...
Medtronic announced on ... Deep brain stimulation involves a minimally invasive procedure in which a neurostimulator is implanted that transmits electrical signals to the parts of the brain ...
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...
Medtronic today announced the official launch of its CD Horizon ModuLeX spinal system for deformity procedures.
It uses a surgically implanted neurostimulator via a minimally ... minimizing the need for patients to manually adjust stimulation. "Medtronic is the only company in the world to offer an adaptive ...
On Feb 24, the FDA approved Medtronic’s BrainSense Adaptive deep brain stimulation, a device that surgeons implant in patients’ chests with electrodes connecting to the brain. The system is ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
minimizing the need for patients to manually adjust stimulation. BrainSense Adaptive DBS is available to Medtronic DBS patients with Parkinson’s who have been implanted with a Percept ...